HKD 87.7
(0.86%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 2.99 Billion CNY | 59.17% |
2022 | 1.87 Billion CNY | 118.65% |
2021 | 859.42 Million CNY | 331.89% |
2020 | 198.99 Million CNY | 30.87% |
2019 | 152.05 Million CNY | 133.76% |
2018 | 65.04 Million CNY | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 3.3 Billion CNY | 0.0% |
2023 FY | 2.99 Billion CNY | 59.17% |
2023 Q2 | 2.74 Billion CNY | 0.0% |
2023 Q4 | 2.99 Billion CNY | 0.0% |
2022 FY | 1.87 Billion CNY | 118.65% |
2022 Q2 | 1.55 Billion CNY | 0.0% |
2022 Q4 | 2.1 Billion CNY | 0.0% |
2021 FY | 859.42 Million CNY | 331.89% |
2021 Q2 | 544.82 Million CNY | 0.0% |
2021 Q4 | 1.05 Billion CNY | 0.0% |
2020 Q4 | 235.93 Million CNY | 0.0% |
2020 FY | 198.99 Million CNY | 30.87% |
2020 Q2 | 315.2 Million CNY | 0.0% |
2019 Q4 | 1.47 Billion CNY | 0.0% |
2019 FY | 152.05 Million CNY | 133.76% |
2019 Q2 | 89.91 Million HKD | 0.0% |
2018 FY | 65.04 Million CNY | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Uni-Bio Science Group Limited | 52.86 Million HKD | -5557.408% |
CK Life Sciences Int'l., (Holdings) Inc. | 5.93 Billion HKD | 49.573% |